SBP Provides a Business Update and Reports Q3 2019 Financial Results

  • Enrollment in Third Cohort of the PDA Combination Study completed; Fourth Cohort planned
  • New U.S. sites added in anticipation of further clinical development
  • Company raised $3.1 million in new capital

View/download press release »